C129H125ClF7N23O13S2 — CID 167706944
4-[2-(1-acetylpiperidin-4-yl)ethyl]-2-(1H-benzimidazol-2-yl)-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-3-one;4-[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]-N-(cyclopropylmethyl)benzamide;2-(6-chloro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;4-[2-(4-fluorophenyl)ethyl]-5-[3-(4-fluorophenyl)propyl]-2-(1H-imidazo[4,5-b]pyridin-2-yl)-1H-pyrazol-3-one (PubChem CID 167706944) has the molecular formula C129H125ClF7N23O13S2 and a molecular weight of 2438.14 g/mol. Its IUPAC name is 4-[2-(1-acetylpiperidin-4-yl)ethyl]-2-(1H-benzimidazol-2-yl)-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-3-one;4-[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]-N-(cyclopropylmethyl)benzamide;2-(6-chloro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;4-[2-(4-fluorophenyl)ethyl]-5-[3-(4-fluorophenyl)propyl]-2-(1H-imidazo[4,5-b]pyridin-2-yl)-1H-pyrazol-3-one.
| Compound Name | 4-[2-(1-acetylpiperidin-4-yl)ethyl]-2-(1H-benzimidazol-2-yl)-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-3-one;4-[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]-N-(cyclopropylmethyl)benzamide;2-(6-chloro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;4-[2-(4-fluorophenyl)ethyl]-5-[3-(4-fluorophenyl)propyl]-2-(1H-imidazo[4,5-b]pyridin-2-yl)-1H-pyrazol-3-one |
|---|---|
| PubChem CID | 167706944 |
| Molecular Formula | C129H125ClF7N23O13S2 |
| Molecular Weight | 2438.14 g/mol |
| Exact Mass | 2435.88 |
| IUPAC Name | 4-[2-(1-acetylpiperidin-4-yl)ethyl]-2-(1H-benzimidazol-2-yl)-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-3-one;4-[2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-3-oxo-1H-pyrazol-5-yl]-N-(cyclopropylmethyl)benzamide;2-(6-chloro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-5-(4-methylsulfonylphenyl)-4-[2-(oxan-4-yl)ethyl]-1H-pyrazol-3-one;4-[2-(4-fluorophenyl)ethyl]-5-[3-(4-fluorophenyl)propyl]-2-(1H-imidazo[4,5-b]pyridin-2-yl)-1H-pyrazol-3-one |
| SMILES | CC(=O)N1CCC(CCc2c(-c3ccc(C(F)(F)F)cc3)[nH]n(-c3nc4ccccc4[nH]3)c2=O)CC1.CS(=O)(=O)c1ccc(-c2[nH]n(-c3nc4ccc(Cl)cc4[nH]3)c(=O)c2CCC2CCOCC2)cc1.CS(=O)(=O)c1ccc(-c2[nH]n(-c3nc4ccc(F)cc4[nH]3)c(=O)c2CCC2CCOCC2)cc1.O=C(NCC1CC1)c1ccc(-c2[nH]n(-c3nc4ccccc4[nH]3)c(=O)c2CCc2ccc(F)cc2)cc1.O=c1c(CCc2ccc(F)cc2)c(CCCc2ccc(F)cc2)[nH]n1-c1nc2ncccc2[nH]1 |
| InChI | InChI=1S/C29H26FN5O2.C26H26F3N5O2.C26H23F2N5O.C24H25ClN4O4S.C24H25FN4O4S/c30-22-14-7-18(8-15-22)9-16-23-26(20-10-12-21(13-11-20)27(36)31-17-19-5-6-19)34-35(28(23)37)29-32-24-3-1-2-4-25(24)33-29;1-16(35)33-14-12-17(13-15-33)6-11-20-23(18-7-9-19(10-8-18)26(27,28)29)32-34(24(20)36)25-30-21-4-2-3-5-22(21)31-25;27-19-11-6-17(7-12-19)3-1-4-22-21(15-10-18-8-13-20(28)14-9-18)25(34)33(32-22)26-30-23-5-2-16-29-24(23)31-26;2*1-34(31,32)18-6-3-16(4-7-18)22-19(8-2-15-10-12-33-13-11-15)23(30)29(28-22)24-26-20-9-5-17(25)14-21(20)27-24/h1-4,7-8,10-15,19,34H,5-6,9,16-17H2,(H,31,36)(H,32,33);2-5,7-10,17,32H,6,11-15H2,1H3,(H,30,31);2,5-9,11-14,16,32H,1,3-4,10,15H2,(H,29,30,31);2*3-7,9,14-15,28H,2,8,10-13H2,1H3,(H,26,27) |
| InChIKey | KWWDNTPLWZNABS-UHFFFAOYSA-N |
| XLogP | 22.10 |
| TPSA | 481.39 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 175 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2438.14 |
| LogP ≤ 5 | 22.10 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 24 |